COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021

Details

• Journal Article:
  Morbidity and Mortality Weekly Report
• Personal Author:
  Black, Carla L. ; Cole, Matthew M. ; Fitter, David L. ; Harris, LaTreace Q. ; Kriss, Jennifer L. ; Reynolds, Laura E. ; Ritchey, Matthew D. ; Rose, Dale A. ; Shaw, Lauren K. ; Singleton, James A. ; Stokley, Shannon ; Toblin, Robin L. ; Wang, Alice
• Corporate Authors:
  CDC COVID-19 Vaccine Task Force
• Description:
  What is already known about this topic? During December 2020, two 2-dose COVID-19 vaccines received Emergency Use Authorization from the Food and Drug Administration. What is added by this report? Among persons who received a first dose and for whom sufficient time had elapsed to receive the second dose, 88.0% had completed the series; 8.6% had not received the second dose but were still within the allowable interval to receive it. Among all 2-dose recipients, 95.6% received the second dose within the recommended interval. Differences in missed doses or second doses administered outside the recommended interval were identified among jurisdictions and demographic groups. What are the implications for public health practice? Identifying and addressing possible barriers to completing the COVID-19 vaccination series can help ensure equitable coverage across communities and optimal health benefits for recipients. [Description provided by NIOSH]
• Subjects:
  Communicable Diseases Coronavirus COVID-19 COVID-19 Vaccines Emergency Responders Health Care Facilities Workforce And Services Health Personnel Health Services Accessibility Immunization Schedule Occupational Health Public Health Risk Assessment Safety Safety Management Time Factors Vaccination Coverage Viral Diseases

  More +
• Keywords:
  Humans; Vaccines; Medical monitoring; Safety monitoring; Medical personnel; Health care; Public health; Coronavirus; COVID-19; Disease prevention; Viral diseases; Infection control; Risk management; Recommendations; Emergency treatment; Compliance; Medical treatment; Health services
• Source:
  MMWR 2021 Mar; 70(11):389-395
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195
• Pubmed ID:
  33735162
• Pubmed Central ID:
  PMC7976616
• Document Type:
  Text
• Genre:
  Journal Article
• Place as Subject:
  Georgia ; Ohio ; OSHA Region 4 ; OSHA Region 5
• CIO:
  National Institute for Occupational Safety and Health (NIOSH)
• Division:
  DFSE - Division of Field Studies and Engineering
• Topic:
  Workplace Safety & Health
• Location:
  North America
• Pages in Document:
  7 pdf pages
• Volume:
  70
• Issue:
  11
• NIOSHTIC Number:
  nn:20062255
• Contact Point Address:
  Jennifer L. Kriss, PhD, CDC COVID-19 Response Team, Atlanta, GA
• Email:
  jkriss@cdc.gov
• Federal Fiscal Year:
  2021
• NORA Priority Area:
  Services
• Peer Reviewed:
  False
• Collection(s):
  National Institute for Occupational Safety and Health Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:2e18e055724960e5876249d264d35429070f45372288132698a671bd0bc0c92b377f24c11e4dd9de9ebf002e98d95e8a7d4d70ac3e6a6a7482bc9d0c7f4e3974
• Download URL:
  https://stacks.cdc.gov/view/cdc/104796/cdc_104796_DS1.pdf
• File Type:
  [PDF - 153.27 KB ]